DNA damage enhancement from gold nanoparticles for clinical MV photon beams

Radiation Research

Volumn 178, Issue 6, 2012, Pages 604-608

  Berbeco, Ross I ^a   Korideck, Houari ^a   Ngwa, Wilfred ^a   Kumar, Rajiv ^b   Patel, Janki ^b   Sridhar, Srinivas ^b   Johnson, Sarah ^c   Price, Brendan D ^c   Kimmelman, Alec ^a   Makrigiorgos, G Mike ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE;

ARTICLE; DNA DAMAGE; HELA CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; PHOTON; PRIORITY JOURNAL; RADIATION BEAM; RADIATION FIELD;

DNA DAMAGE; GOLD; HELA CELLS; HUMANS; METAL NANOPARTICLES; PHOTONS;

EID: 84870866852     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3001.1     Document Type: Article

References (27)

1. Lasagna-Reeves C, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Comm 2010; 393(4):649-55.
2. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011; 40(3):1647-71.
3. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Bio 2004; 49(18):N309-15.
4. Cho SH. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Bio 2005; 50(15):N163-73.
5. Roeske JC, Nunez L, Hoggarth M, Labay E, Weichselbaum RR. Characterization of the theorectical radiation dose enhancement from nanoparticles. Tech Cancer Res Treat 2007; 6(5):395-401.
6. Berbeco RI, Ngwa W, Makrigiorgos GM. Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage x-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Bio Phys2011; 81(1):270-6.
7. Cho SH, Jones BL, Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Phys Med Bio 2009; 54(16):4889-905.
8. Chithrani DB, et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 2010; 173(6):719-28.
9. Jain S, et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Bio Phys 2011; 79(2):531-9.
10. McMahon SJ, et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother Oncol 2011; 100(3): 412-6.
11. Berbeco RI, Ngwa W, Makrigiorgos GM. Localized dose enhancement to tumor blood vessel endothelial cells via targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Bio Phys 2011; 81(1):270-6.
12. Ling CC, Gerweck LE, Zaider M, Yorke E. Dose-rate effects in external beam radiotherapy redux. Radiother Oncol 2010; 95(3): 261-8.
13. Xu Y, et al. The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J Cell Biol 2010; 191(1):31-43.
14. Camphausen K, et al. Enhanced radiation-induced cell killing and prolongation of gamma H2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 2004; 64(1):316-21.
15. Ngwa W, Makrigiorgos GM, Berbeco RI. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Phys Med Bio 2010; 55(21):6533-48.
16. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006; 79(939):248-53.
17. Aydogan B, et al. AuNP-DG: Deoxyglucose-labeled gold nanoparticles as x-ray computed tomography contrast agents for cancer imaging. Molec Imag Bio; 12(5):463-7.
18. Kojima C, et al. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in pegylated dendrimer. Nanotechnology; 21(24).
19. Boote E, et al. Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography. Academic Radiology; 17(4): 410-7.
20. Li J, et al. A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Bio 55(15):4389-97.
21. Berbeco R, Korideck H, Yue Y, Makrigiorgos M. Gold nanoparticles as a contrast agent for in-treatment tumor tracking. Med Phys 2011; 38(6):3476.
22. Shenoy D, et al. Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomed 2006; 1(1):51-7.
23. Bergen JM, Von Recum HA, Goodman TT, Massey AP, Pun SH. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromolec Biosci 2006, 6(7):506-16.
24. Paciotti GF, Kingston DGI, Tamarkin L. Colloidal gold nanoparticles: A novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors. Drug Devel Res 2006; 67(1):47-54.
25. De M, Ghosh PS, Rotello VM. Applications of Nanoparticles in Biology. Adv Mater 2008; 20(22):4225-41.
26. Duncan B, Kim C, Rotello VM. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Contr Rel 148(1): 122-7.
27. Nagesha DK, et al. Radiosensitizer-eluting nanocoatings on gold fiducials for biological in-situ image-guided radiotherapy (BIS-IGRT). Phys Med Bio 55(20):6039-52.